Cargando…

Regarding Combined Pediatric and Adult Trials Submitted to the US Food and Drug Administration 2012–2018

Detalles Bibliográficos
Autores principales:	Cook, Jack, Weiner, Dan, Powell, J. Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246746/ https://www.ncbi.nlm.nih.gov/pubmed/33166413 http://dx.doi.org/10.1002/cpt.2076

Ejemplares similares

A Proposed Framework for Patient-Focused Policy at the U.S. Food and Drug Administration
por: Kuehn, Carrie M.
Publicado: (2019)

Listening session with the US Food and Drug Administration, Lewy Body Dementia Association, and an expert panel
por: Sabbagh, Marwan N., et al.
Publicado: (2023)

US Food and Drug Administration embraces using innovation to identify optimized dosages for patients with cancer
por: Shord, Stacy S., et al.
Publicado: (2023)

Monoclonal Antibodies and Fc‐Fusion Proteins for Pediatric Use: Dosing, Immunogenicity, and Modeling and Simulation in Data Submitted to the US Food and Drug Administration
por: Liu, Xiaomei I., et al.
Publicado: (2019)

A Real‐World Evidence Framework for Optimizing Dosing in All Patients With COVID‐19
por: Peck, Richard W., et al.
Publicado: (2020)

Case Study for Lean Management in the Public Sector: Improving Combination Product Review at the Food & Drug Administration
por: Rappel, MJ, et al.
Publicado: (2017)

Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration
por: Stone, Marc, et al.
Publicado: (2009)

Monitoring Effect of Human Papillomavirus Vaccines in US Population, Emerging Infections Program, 2008–2012
por: Hariri, Susan, et al.
Publicado: (2015)

Cosmetics and Cancer: Adverse Event Reports Submitted to the Food and Drug Administration
por: Jacob, Saya L, et al.
Publicado: (2018)

Reporting Bias in Drug Trials Submitted to the Food and Drug Administration: Review of Publication and Presentation
por: Rising, Kristin, et al.
Publicado: (2008)

The Significance of Information Posted on the U.S. Food and Drug Administration’s Website
por: Cook, G. Elliott, et al.
Publicado: (2013)

Concerns of CropLife America Regarding the Application and Use of the U.S. EPA’s Toxicity Reference Database
por: Janus, Erik
Publicado: (2009)

Minimum Technical Data Elements for Liquid Biopsy Data Submitted to Public Databases
por: Febbo, Phillip G., et al.
Publicado: (2020)

Correction: Reporting Bias in Drug Trials Submitted to the Food and Drug Administration: Review of Publication and Presentation
por: Rising, Kristin, et al.
Publicado: (2009)

In Vitro‐to‐In Vivo Extrapolation of Transporter Inhibition Data for Drugs Approved by the US Food and Drug Administration in 2018
por: Yu, Jingjing, et al.
Publicado: (2020)

US Food and Drug Administration Accelerated Approval Program for Nononcology Drug Indications Between 1992 and 2018
por: Omae, Kenji, et al.
Publicado: (2022)

Temporary Regulatory Deviations and the Coronavirus Disease 2019 (COVID-19) PCR Labeling Update Study Indicate What Laboratory-Developed Test Regulation by the US Food and Drug Administration (FDA) Could Look Like
por: Marble, Hetal D., et al.
Publicado: (2021)

Disagreements Within the US Food and Drug Administration Regarding Approval of Novel Therapeutic Agents, 2011-2015
por: MacGregor, Andrea, et al.
Publicado: (2020)

US Food and Drug Administration Warning Regarding Finasteride and Suicidal Ideation: What Should Urologists Know?
por: Al Saffar, Haidar, et al.
Publicado: (2023)

Proposed U.S. regulation of gene-edited food animals is not fit for purpose
por: Van Eenennaam, Alison L., et al.
Publicado: (2019)

Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration
por: Kirsch, Irving, et al.
Publicado: (2008)

Response to acute monotherapy for major depressive disorder in randomized, placebo controlled trials submitted to the US Food and Drug Administration: individual participant data analysis
por: Stone, Marc B, et al.
Publicado: (2022)

Abandon of intramuscular administration of rabies immunoglobulin for post-exposure prophylaxis in the revised guidelines in the Netherlands in 2018: cost and volume savings
por: Schreuder, Imke, et al.
Publicado: (2020)

Practice Trends and Characteristics of US Hospitalists From 2012 to 2018
por: Ryskina, Kira L., et al.
Publicado: (2021)

Conflicting information from the Food and Drug Administration: Missed opportunity to lead standards for safe and effective medical artificial intelligence solutions
por: Hernandez-Boussard, Tina, et al.
Publicado: (2021)

Perspective: Putting the youngest among us into the nutrition “call for action” for food fortification strategies
por: Zlotkin, Stanley, et al.
Publicado: (2021)

Case series of reports of pruritus and sipuleucel-T submitted to the Food and Drug Administration Adverse Event Reporting System
por: Dores, Graça M., et al.
Publicado: (2019)

Postmarketing safety of orphan drugs: a longitudinal analysis of the US Food and Drug Administration database between 1999 and 2018
por: Fan, Min, et al.
Publicado: (2022)

Cyberpharmacies and the role of the US Food And Drug Administration
por: Henney, Jane E
Publicado: (2001)

The US Food and Drug Administration’s Intersection with Dermatology
por: Luke, Markham C.
Publicado: (2022)

Pediatric dosing for locally acting drugs in submissions to the U.S. Food and Drug Administration between 2002 and 2020
por: Abulwerdi, Gelareh A., et al.
Publicado: (2023)

Change in Colorectal Cancer Tests Submitted for Reimbursement in Switzerland 2012–2018: Evidence from Claims Data of a Large Insurance
por: Schneider, Rémi, et al.
Publicado: (2021)

Postmarket studies required by the US Food and Drug Administration for new drugs and biologics approved between 2009 and 2012: cross sectional analysis
Publicado: (2018)

The Value of Food Allergy Prevention in Clinical Practice in Pediatrics: Targeting Early Life
por: Anagnostou, Katherine, et al.
Publicado: (2018)

Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration
por: Huedo-Medina, Tania B, et al.
Publicado: (2012)

Analysis of 408 Total Ankle Arthroplasty Adverse Events Reported to the US Food and Drug Administration from 2015-2018
por: Chen, Jie, et al.
Publicado: (2020)

Calorie and nutrient trends in large U.S. chain restaurants, 2012-2018
por: Bleich, Sara N., et al.
Publicado: (2020)

Antibodies to watch in 2018
por: Kaplon, Hélène, et al.
Publicado: (2018)

Celebrating the World Blood Donor Day 2012
por: Kim, Sunhee
Publicado: (2012)

Public opinion regarding U.S. Food and Drug Administration approval of aducanumab and potential policy responses: A nationally representative survey
por: DiStefano, Michael J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ej507bbuq3a7d4qvfqbvq1qui9